RESUMO
Laparoscopic retropubic urethropexy by Birch was followed by chemotherapy with m-cholinolytics in 30 women with mixed urinary incontinence. 15 patients received trospium chloride in a daily dose 30-45 mg and the other 15--oxibutinin hydrochloride in a daily dose 10-15 mg. A comparative analysis of the treatment results after 36 months of follow-up demonstrated higher safety of trospium chloride which showed the same efficacy with oxibutinin hydrochloride.
Assuntos
Ácidos Mandélicos/uso terapêutico , Antagonistas Muscarínicos/uso terapêutico , Nortropanos/uso terapêutico , Incontinência Urinária , Benzilatos , Terapia Combinada , Feminino , Humanos , Laparoscopia , Ácidos Mandélicos/administração & dosagem , Pessoa de Meia-Idade , Antagonistas Muscarínicos/administração & dosagem , Nortropanos/administração & dosagem , Índice de Gravidade de Doença , Resultado do Tratamento , Incontinência Urinária/tratamento farmacológico , Incontinência Urinária/etiologia , Incontinência Urinária/cirurgia , Procedimentos Cirúrgicos UrológicosRESUMO
Stress urine incontinence was treated in 79 women with Burch laparoscopic colposuspension, 75 (94.9%) of them had chronic urinary infection. 42 females of group 1 received postoperative extracorporeal hemocorrection, 37 females of group 2 received conventional postoperative therapy. In group 1 the treatment reduced leukocyturia, bacteriuria was detected in 9 (21.4%) patients, recurrent incontinence occurred in 2 (5.9%) women. In group 2 leukocyturia enhanced, bacteriuria and incontinence recurrence were observed in 23 (62.2%) and 8 (23.5%) patients, respectively. The results of the study show that combined use of laparoscopic colposuspension by Burch and extracorporeal hemocorrection improves the results of the treatment of stress urine incontinence.
